Cutting edge: Enhanced IL-2 signaling can convert self-specific T cell response from tolerance to autoimmunity

Journal of Immunology

Volumn 180, Issue 9, 2008, Pages 5789-5793

  Waithman, Jason ^a   Gebhardt, Thomas ^a   Davey, Gayle M ^b   Heath, William R ^b   Carbone, Francis R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; AUTOANTIGEN; GRANZYME; GZMB PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; ANTIGEN PRESENTATION; CELL MOTION; CYTOLOGY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MOUSE; PHYSIOLOGY; SKIN; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; AUTOIMMUNITY; CELL MOVEMENT; DENDRITIC CELLS; GRANZYMES; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; INTERLEUKIN-2; MICE; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; SKIN; T-LYMPHOCYTES;

EID: 44449094182     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.9.5789     Document Type: Article

References (24)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60. (Pubitemid 26110754)
2. Bachmann, M. F., M. Barner, A. Viola, and M. Kopf. 1999. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur. J. Immunol. 29: 291-299. (Pubitemid 29043547)
3. Zimmermann, C., A. Prevost-Blondel, C. Blaser, and H. Pircher. 1999. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur. J. Immunol. 29: 284-290. (Pubitemid 29043546)
4. Rogers, P. R., C. Dubey, and S. L. Swain. 2000. Qualitative changes accompany memory T cell generation: faster, more effective responses at lower doses of antigen. J. Immunol. 164: 2338-2346. (Pubitemid 30115460)
5. Stock, A. T., C. M. Jones, W. R. Heath, and F. R. Carbone. 2006. Cutting edge: central memory T cells do not show accelerated proliferation or tissue infiltration in response to localized herpes simplex virus-1 infection. J. Immunol. 177: 1411-1415. (Pubitemid 44092472)
6. + T cells undergo peripheral tolerance. Immunity 17: 73-81.
7. + T-cell responses. Blood 111: 2091-2100.
8. Redmond, W. L., and L. A. Sherman. 2005. Peripheral tolerance of CD8 T lymphocytes. Immunity 22: 275-284. (Pubitemid 40387470)
9. Azukizawa, H., H. Kosaka, S. Sano, W. R. Heath, I. Takahashi, X. H. Gao, Y. Sumikawa, M. Okabe, K. Yoshikawa, and S. Itami. 2003. Induction of T-cell-mediated skin disease specific for antigen transgenically expressed in keratinocytes. Eur. J. Immunol. 33: 1879-1888. (Pubitemid 37120859)
10. Waithman, J., R. S. Allan, H. Kosaka, H. Azukizawa, K. Shortman, M. B. Lutz, W. R. Heath, F. R. Carbone, and G. T. Belz. 2007. Skin-derived dendritic cells can mediate deletional tolerance of class I-restricted self-reactive T cells. J. Immunol. 179: 4535-4541.
11. Morgan, D. J., C. Kurts, H. T. Kreuwel, K. L. Holst, W. R. Heath, and L. A. Sherman. 1999. Ontogeny of T cell tolerance to peripherally expressed antigens. Proc. Natl. Acad. Sci. USA 96: 3854-3858. (Pubitemid 29169000)
12. + T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med. 194: 707-717.
13. Kurts, C., J. F. Miller, R. M. Subramaniam, F. R. Carbone, and W. R. Heath. 1998. Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J. Exp. Med. 188: 409-414. (Pubitemid 28357770)
14. Kurts, C., R. M. Sutherland, G. Davey, M. Li, A. M. Lew, E. Blanas, F. R. Carbone, J. F. Miller, and W. R. Heath. 1999. CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc. Natl. Acad. Sci. USA 96: 12703-12707. (Pubitemid 29513566)
15. + TH-17 cells in relapsing EAE. Nat. Immunol. 8: 172-180.
16. + T cells. Nat. Immunol. 8: 1060-1066.
17. Boyman, O., M. Kovar, M. P. Rubinstein, C. D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311: 1924-1927.
18. Kurts, C., H. Kosaka, F. R. Carbone, J. F. Miller, and W. R. Heath. 1997. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8+ T cells. J. Exp. Med. 186: 239-245. (Pubitemid 27328024)
19. + T cells pass through an effector phase during the process of in vivo tolerance induction. J. Immunol. 170: 3945-3953.
20. Heath, W. R., J. Allison, M. W. Hoffmann, G. Schonrich, G. Hammerling, B. Arnold, and J. F. Miller. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359: 547-549.
21. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337. (Pubitemid 46328484)
22. Gajewski, T. F., Y. Meng, and H. Harlin. 2006. Immune suppression in the tumor microenvironment. J. Immunother. 29: 233-240. (Pubitemid 44297291)
23. Waldmann, T. A. 2006. The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6: 595-601. (Pubitemid 44134092)
24. + T cells. Nat. Immunol. 8: 1353-1362.